Association between the NEP rs701109 polymorphism and the clinical efficacy and safety of sacubitril/valsartan in Chinese patients with heart failure.
第一作者:
Hong-Yu,Luo
第一单位:
School of Pharmacy, Department of Pharmacy, Phase I Clinical Trial Centre, the Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, China.
作者:
主题词
人类(Humans);血管紧张素受体拮抗剂(Angiotensin Receptor Antagonists);联苯化合物(Biphenyl Compounds);复方合剂(Drug Combinations);心力衰竭(Heart Failure);低血压(Hypotension);脑啡肽酶(Neprilysin);多态现象, 遗传(Polymorphism, Genetic);每搏输出量(Stroke Volume);四唑类(Tetrazoles);治疗结果(Treatment Outcome)
DOI
10.1007/s00228-023-03484-6
PMID
36976322
发布时间
2023-04-25
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文